1-cyclopropyl-6-fluoro-4-oxo-7-(4-((5-(2-oxo-2-phenylethylthio)-1,3,4-oxadiazol-2-yl)methyl)piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid

ID: ALA4209112

PubChem CID: 145967061

Max Phase: Preclinical

Molecular Formula: C28H26FN5O5S

Molecular Weight: 563.61

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  O=C(CSc1nnc(CN2CCN(c3cc4c(cc3F)c(=O)c(C(=O)O)cn4C3CC3)CC2)o1)c1ccccc1

Standard InChI:  InChI=1S/C28H26FN5O5S/c29-21-12-19-22(34(18-6-7-18)14-20(26(19)36)27(37)38)13-23(21)33-10-8-32(9-11-33)15-25-30-31-28(39-25)40-16-24(35)17-4-2-1-3-5-17/h1-5,12-14,18H,6-11,15-16H2,(H,37,38)

Standard InChI Key:  JHTUKWVELYLRCK-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 40 45  0  0  0  0  0  0  0  0999 V2000
   25.9341   -9.1542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.9329   -9.9737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6410  -10.3827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.6392   -8.7453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3478   -9.1506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.3466   -9.9757    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0567  -10.3871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   28.7726   -9.9778    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.7738   -9.1526    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0591   -8.7367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.4826   -8.7452    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.1893   -9.1555    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.4846   -7.9280    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.0591   -7.9195    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.2263   -8.7457    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   25.2262  -10.3834    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.5189   -9.9720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8130  -10.3766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.8082  -11.1941    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.5154  -11.6055    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.2275  -11.1993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.0582  -11.2043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.6476  -11.9109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4648  -11.9132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.0986  -11.5995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3928  -11.1876    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3082  -10.3777    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5097  -10.2041    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.0978  -10.9100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6419  -11.5197    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.2847  -10.9918    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   19.8074  -10.3285    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.9943  -10.4103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5169   -9.7470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6585  -11.1553    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   18.8565   -9.0054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3798   -8.3426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.5658   -8.4240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2308   -9.1740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7095   -9.8337    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 11 12  1  0
 11 13  2  0
  9 11  1  0
 10 14  2  0
  1 15  1  0
 16 17  1  0
 16 21  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 21  1  0
  2 16  1  0
 23 22  1  0
 24 23  1  0
 22 24  1  0
  7 22  1  0
 19 25  1  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 30  1  0
 30 26  1  0
 29 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 33 35  2  0
 34 36  2  0
 36 37  1  0
 37 38  2  0
 38 39  1  0
 39 40  2  0
 40 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4209112

    ---

Associated Targets(Human)

LOX IMVI (44321 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-92 (41141 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MOLT-4 (49676 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HOP-62 (47048 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-OV-3 (52876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
UO-31 (46270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 563.61Molecular Weight (Monoisotopic): 563.1639AlogP: 3.85#Rotatable Bonds: 9
Polar Surface Area: 121.77Molecular Species: ACIDHBA: 10HBD: 1
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 5.87CX Basic pKa: 3.45CX LogP: 2.95CX LogD: 1.41
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.24Np Likeness Score: -1.62

References

1. Kassab AE, Gedawy EM..  (2018)  Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.,  150  [PMID:29547830] [10.1016/j.ejmech.2018.03.026]

Source